Opinion – Tuesday 2 March 2021

U.S. Equity Markets surged to start the week, finishing the day higher, led by both the S&P and NASDAQ which closed higher by 2.38% and 3.01% respectively. Equity markets rose in the early morning and held onto their gains. Vaccine optimism was a key driver,...

Opinion – Monday 1 March 2021

U.S. Equity Markets bounced around on a volatile end to the week closing mixed with the Dow falling 1.50% while the NASDAQ 100 closed higher by 0.63%. Equities sold off sharply at the open before recovering. Personal Consumption Expenditures (“PCE”) was...

Opinion – Friday 26 February 2021

U.S. Equity Markets have resumed their decline, finishing the day lower led by the NASDAQ which fell 3.56%, while the VIX surged 34%, closing above both its 50 and 200 Day Moving Averages at a price of 28.57. Rising bond yields again forced an equity sell-off....

Opinion – Thursday 25 February 2021

U.S. Equity Markets broke their losing streak on vaccine optimism, finishing higher, led by the Dow rallying to a new all-time high with a gain of 1.35%. Vaccine optimism was the main driver for yesterday’s gains. Ahead of an advisory committee review, an analysis by...

Opinion – Wednesday 24 February 2021

U.S. Equity Markets tried to break their losing streak, ending yesterday’s trading session mixed as the S&P closed with a tiny gain of 0.13%, while the NASDAQ 100 closed just 0.22% lower, reversing an earlier 4% fall. Markets declined again, with Interest Rates...

Opinion – Tuesday 23 February 2021

U.S. Equity Markets declined to start the week, led by the NASDAQ 100 which closed lower by 2.63% as the S&P fell for the fifth straight session. Markets declined in the morning, before recovering throughout the day. Rising bond yields were a key reason for the...

Opinion – Monday 22 February 2021

U.S. Equity Markets rose in the early morning but fell throughout the day, ending the week mixed, as the S&P closed lower for the fourth consecutive trading session, while the Small Cap Russell 2000 closed with a gain of 2.06%. Treasury Secretary Janet Yellen...

Opinion – Friday 19 February 2021

U.S. Equity Markets closed lower despite strong economic data, led again by the Small Cap Russell 2000, ending yesterday with a loss of 1.53%. Markets fell for the second straight day. Jobs data were one of the reasons for the selling. Jobless Claims rose and came in...

Opinion – Thursday 18 February 2021

U.S. Equity Markets closed lower yesterday, despite strong economic data. The Russell 2000 led the declines, closing lower by 0.78% while the Dow booked the trend, closing at a new all-time high with a gain of 0.29%. Retail Sales rose 5.3% from the month prior,...

Opinion – Wednesday 17 February 2021

U.S. Equity Markets opened at new all-time highs before having a small sell-off into the close. Although the Dow closed 0.20% higher, both the S&P and NASDAQ closed with small losses. All eyes are on stimulus and vaccine news. With former president Donald...

Opinion – Tuesday 16 February 2021

U.S Equity Futures rallied to new all-time highs despite yesterday’s Presidents’ Day Holiday. The S&P is currently trading at 3952. U.K. Prime Minister Boris Johnson is drawing up plans for gradually lifting pandemic restrictions on socialising, shopping and...

Opinion – Monday 15 February 2021

U.S. Equity Markets traded sideways for most of Friday’s session before a late surge saw both the S&P and NASDAQ 100 close at new all-time highs as both Indexes gained 0.5%. Vaccine optimism boosted markets throughout Friday. President Joe Biden said the...

Opinion – Friday 12 February 2021

U.S. Equity Markets continued their choppy week, finishing the day higher after yet another reversal from a quick sell-off, led by the NASDAQ 100 which closed higher by 0.58%. Markets were mixed as investors digested Jobless Claims data. Jobless Claims fell from last...

Opinion – Thursday 11 February 2021

U.S. Equity Markets recovered from an early sell-off to closed mixed with the S&P ending the day with a small loss of 0.03% while the Dow closed 0.20% higher. Early in the day, markets rose on COVID-19 treatment news. Pharmaceutical giant Eli Lilly’s...